Signals in Milk: Early Detection of Bovine Mastitis Using Milk Biomarkers

Think about your daily morning routine. Maybe you pour a bowl of milk before your cereal (that is the correct order!), add a quick splash into your coffee, or chug a glass before heading out the door. Milk is such a fundamental part of our life that we rarely pause to think about where it comes from or the animals providing it.

Behind every carton of milk we uncap, there is a dairy cow whose health impacts the milk we eventually drink. One of the largest threats to that health is a disease called mastitis. According to the United States Department of Agriculture, mastitis causes an estimated $1.9 billion in annual economic loss to the U.S. dairy industry alone. Mastitis, an inflammation of the udder often caused by bacterial infections, is consistently ranked as the most costly disease, plaguing dairy cattle worldwide. Yet, despite this single condition’s responsibility for reduced milk yields, wasted milk, staggering veterinary expenses, and early culling, mastitis is often diagnosed only after irreversible damage has taken root.

Dairy cattle are a fundamental part of modern agriculture, supplying vital nutrients and resources to millions of people while sustaining the livelihoods of farmers across the globe. When the health and longevity of these creatures are threatened, the consequences extend far beyond one individual farm. So, what exactly is this costly and detrimental condition? Mastitis, an inflammatory disease of the mammary gland, occurs in both clinical and subclinical forms. Clinical mastitis presents with textbook symptoms, often visible through swelling, abnormal milk, and fever. Subclinical mastitis shows no outward symptoms and, as a result, often goes undetected. Unfortunately, despite its lack of signs, subclinical mastitis is significantly more prevalent and economically damaging compared to its counterpart. According to the National Mastitis Council in 2022, subclinical cases account for the majority of mastitis-related losses and can reduce milk production by up to fifteen percent per individual cow. This lack of ability to detect early disease onset is exactly what allows mastitis to persist and continue as one of the most costly and harmful diseases faced by the dairy industry today.

Currently, traditional mastitis detection relies on visual inspection, somatic cell counts, and antibiotic treatment post-diagnosis. Somatic cell count, or SCC, is a common indicator of udder health with elevated levels indicating immune cell reaction to a possible infection. However, this method is inconsistent and unreliable, as SCC often rises only after inflammation has progressed, at which point cellular damage to mammary tissue has already occurred.

Antibiotic therapy remains the key strategy utilized once diagnosis is made. While effective in combating bacterial pathogens, antibiotics present with additional complications. During withdrawal periods, the milk collected must be discarded, further increasing financial losses for farmers. Furthermore, the U.S. Food and Drug Administration has released growing concerns over antimicrobial resistance resulting from continuous livestock antibiotic dependency. These limitations highlight the critical weakness across current mastitis strategies: a reactive rather than preventative approach.

So, what if we could detect mastitis before the damage is done? In Part 2, I’ll explore how researchers are using biomarkers hidden within milk as early warning signals of disease.